The National Institutes of Health has halted all new grants for studies involving human fetal tissue from elective abortions, with scientists warning the move will delay treatments for HIV, cancer and other serious diseases.
The laboratory doors are closing on a controversial chapter of medical research. The US National Institutes of Health announced it will no longer fund any studies involving human fetal tissue from elective abortions, effective immediately.
At the same time, the policy represents a sweeping change from previous restrictions. Unlike earlier measures that targeted only internal NIH projects, this ban includes all research grants, cooperative agreements, and contracts – both inside and outside the agency.
The Numbers Behind the Decision
In fiscal year 2024, NIH supported just 77 grants totalling about £42 million for fetal tissue research. That figure represents a tiny slice – roughly 0.1% – of the agency’s massive £38 billion annual budget.
The number tells a story of decline. Federally-funded fetal tissue research projects have been dropping since 2019, well before this latest announcement. About 60 external grants and nine internal projects face immediate impact, though some reportedly don’t currently use fetal tissue.
Jay Bhattacharya, the NIH Director, framed the decision as modernising biomedical science. The agency stated it reflects a shift toward alternative research methods including organoids, tissue chips, and computational biology.
What Scientists Are Saying
The scientific community has responded with sharp criticism. Researchers argue the ban removes an essential tool for understanding human development and will slow medical discoveries.
But supporters view the policy differently. They see it as an ethically appropriate use of taxpayer funding that aligns with American values even as still advancing medical research through alternative methods.
Projects already underway may continue if researchers can redirect their funding toward other research approaches. The policy forms part of the Trump Administration’s stated goal to modernise biomedical science.
Research Areas at Risk
The ban affects studies across multiple medical fields. HIV research, cancer treatments, brain development studies, and diabetes investigations all rely on fetal tissue research to varying degrees.
During Trump’s first presidency between 2017 and 2021, similar restrictions disrupted studies on HIV, cancer, and coronaviruses. This new policy goes further, covering all NIH-funded research rather than just internal projects.
Source: @bmj_latest
Key Takeaways
- NIH has permanently banned all new funding for research using human fetal tissue from elective abortions
- The policy affects 77 grants worth £42 million, representing 0.1% of NIH’s total budget
- Scientists warn the move will slow medical breakthroughs in HIV, cancer, and other serious diseases
What This Means for Kent Residents
Kent patients may face longer waits for new treatments as this funding ban could slow medical breakthroughs that benefit NHS services. Any local researchers with partnerships involving NIH-funded projects may need to seek alternative funding sources or research methods. For immediate health concerns, residents should continue using NHS 111 for non-emergency medical advice or contact their GP for ongoing health conditions, as existing treatments remain unaffected by this US policy change.